B+ = MoonshotScore 40[9-pillar formula] + Council 3/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].
Q1 consensus: revenue $110.7B[FMP est], EPS $4.83[FMP est]. 3 consecutive quarters of beat[FMP earnings].
2 analysts' median target is $380[FMP target], stock is $369, +3.0% upside potential. After Q1 +9.9% EPS beat[FMP earnings], the stock moved +2.2%.
B+ = MoonshotScore 40[9-pillar formula] + Council 3/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].
Q1 consensus: revenue $110.7B[FMP est], EPS $4.83[FMP est]. 3 consecutive quarters of beat[FMP earnings].
Q1 EPS +9.9% beat[FMP] but the stock +2.2% D+1[FMP D+1]. Wayne DeVeydt promised $763.0M CapEx + a sequential decline in Q1 during the Q1 earnings call[Wayne DeVeydt capex transcript].
Watchlist
Optum Health Margin Improvement
optum_health_margin_improvement
Optum Health is focused on steadily improving margins for 2026 and accelerating into 2027.
"As we have shared over the past 3 quarters, our efforts are focused on management and process improvements that steadily improve margins at Optum Health for 2026 and accelerate into 2027."
- Patrick Conway - Q1 FY26 Earnings Call - April 21, 2026
Medicaid Margin Outlook
medicaid_margin_outlook
UnitedHealthcare expects membership attrition and negative margins in Medicaid in 2026 due to continuing high trend and insufficient funding, with modest margin improvements beginning in 2027.
"We continue to expect membership attrition and negative margins in 2026 in light of continuing high trend and insufficient funding with modest margin improvements beginning in 2027."
- Timothy Noel - Q1 FY26 Earnings Call - April 21, 2026
Margin Recovery Focus
margin_recovery_focus
UnitedHealthcare is prioritizing margin recovery and product stability in 2026, with a deliberate trade-off on membership growth, particularly in Medicare and commercial markets.
"Our 2026 approach prioritizes margin recovery and product stability with a deliberate trade-off on membership growth, particularly in Medicare and commercial markets."
- Timothy Noel - Q1 FY26 Earnings Call - April 21, 2026
Ai Driven Efficiency Optum Insight
ai_driven_efficiency_optum_insight
Optum Insight's new AI-first products continue to gain traction, with Optum Real helping payers and care providers deal more efficiently with administrative functions such as claim adjudication and coverage validation and can reduce manual contact costs by 76%.
"Optum Real is helping payers and care providers deal more efficiently with administrative functions such as claim adjudication and coverage validation and can reduce manual contact costs by 76%."
- Patrick Conway - Q1 FY26 Earnings Call - April 21, 2026
Prior Authorization Improvements
prior_authorization_improvements
UnitedHealthcare is working to improve prior authorization processes, with about 50% of requests now processed in real time, and more than 90% approved on average in 1 business day.
"About 50% of those are processed in real time, and more than 90% are approved on average in 1 business day."
- Timothy Noel - Q1 FY26 Earnings Call - April 21, 2026
Aca Membership Decline
aca_membership_decline
UnitedHealthcare still expects total membership to decline by approximately 1/3 in 2026.
"We still expect total membership to decline by approximately 1/3 in 2026."
- Timothy Noel - Q1 FY26 Earnings Call - April 21, 2026
Stock Expert AI - Methodology
9-pillar methodology. Cash Runway and News Sentiment strong. Revenue Growth weak.
How is it calculated? ->6 investor frameworks. 3 bullish (Ray Dalio, Ken Griffin, Buffett), 1 bearish (Jim Simons), 2 neutral (Klarman, Munger).
How is it calculated? ->Quality business, trading at fair value.
How is it calculated? ->Past Performance
Q1 (April 21, 2026): EPS $7.23 vs $6.58 est[FMP], +9.9% beat. D+1 movement: +2.2%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.
Q1: EPS $7.23 vs $6.58 beat[FMP], stock +2.2% D+1[FMP].
No RPO/backlog concentration disclosed in Q1 earnings call.
Q1 CapEx $763.0M[FMP cashflow]. Q1 op margin 8.0%[FMP op margin] - this level in Q1 is sensitive to CapEx revision risk.
Not advice - a structural framework for earnings night. Decision discipline is yours.
Market Outlook
You read it in 5 minutes. When the numbers come out on Tuesday evening - you know what you're looking at.
Data arrives at night. The framework is ready now.
Data arrives on Tuesday evening. The framework is ready on this page: Q1 EPS threshold $4.83[FMP], CapEx threshold "below $763.0M"[Wayne DeVeydt]. Two anchors, three scenarios.
Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).
Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts
Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing
Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.
Educational tool, not investment advice. Past performance does not guarantee future results.
Calendar
DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.
This UNH (UNH) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.
Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.